Novavax reported $5.97M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Adma Biologics ADMA:US $ 3.25M 0.05M
Agenus AGEN:US $ 16.68M 0.79M
Biocryst Pharmaceuticals BCRX:US $ 13.5M 0.59M
Dynavax Technologies DVAX:US $ 3.11M 1.6M
Mannkind MNKD:US $ 3.18M 3.27M
Moderna Inc MRNA:US 5M 2M
Novartis NVS:US $ 201M 1M
Novavax NVAX:US $ 5.97M 1.13M
Peregrine Pharmaceuticals PPHM:US 703K 461K
Pfizer PFE:US $ 316M 20M
Sarepta Therapeutics SRPT:US $ 15.83M 0.18M
Tg Therapeutics TGTX:US $ 1.62M 0.28M